Nearly unanimous Merck (MRK) shareholders approve the company's $41.1B acquisition of...

|About: Merck & Co Inc. (MRK)|By:, SA News Editor

Nearly unanimous Merck (MRK) shareholders approve the company's $41.1B acquisition of Schering-Plough (SGP), a move that would allow Merck to jump from eighth in prescription drug sales to second, behind Pfizer (PFE). The deal won 99% approval from voters; SGP shareholders vote later this afternoon.